
Another punch to the ribs
IBM can’t catch a clean headline this week. The stock slipped again Friday after JP Morgan kept its Overweight rating but shaved its price target to $250, adding fresh pressure to a name that already got blindsided by a brutal preliminary Q2 update.
The real problem? Confidence is wobbling
This isn’t just about one analyst note. IBM already spooked investors when it said preliminary second-quarter revenue came in at $17.2 billion, below Wall Street’s $17.9 billion target, while earnings landed at $2.93 a share versus expectations of $3.02. That miss lit a match under the stock earlier in the week, and Friday’s downgrade chatter just kept the fire going.
Why you should care
When a stock falls 25%+ in a week, every fresh analyst cut acts like pouring salt on a paper cut — except the paper cut is your portfolio. IBM’s shares were still in a long-term downtrend, and now the market is clearly asking whether this is a temporary stumble or the start of a longer reset.
Big picture: IBM’s AI and enterprise software story still exists, but the market wants cleaner execution, not more excuses.
